Anti-mutated citrullinated vimentin antibodies as a biomarker for interstitial lung disease in patients withrheumatoid arthritis
ARP Rheumatology · 2024
DOI: 10.63032/idqb5912 ↗Kurz gefasst
Fachartikel in der Zeitschrift ARP Rheumatology, 2024. Verfasst von Sahar A Elsayed und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sohag University. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Arthritis, Rheumatoid, Vimentin, Biomarkers. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sohag University.
- Al-Azhar University.
- Menofia University.
Zitieren
APA
Elsayed, S. A., Mohafez, O. M., & Saif, D. S. (2024). Anti-mutated citrullinated vimentin antibodies as a biomarker for interstitial lung disease in patients withrheumatoid arthritis. ARP Rheumatology. https://doi.org/10.63032/idqb5912
Vancouver
Elsayed SA, Mohafez OM, Saif DS. Anti-mutated citrullinated vimentin antibodies as a biomarker for interstitial lung disease in patients withrheumatoid arthritis. ARP Rheumatology. 2024. doi:10.63032/idqb5912
BibTeX
@article{Elsayed2024,
author = {Elsayed, Sahar A and Mohafez, Omar M and Saif, Dalia S},
title = {Anti-mutated citrullinated vimentin antibodies as a biomarker for interstitial lung disease in patients withrheumatoid arthritis},
journal = {ARP Rheumatology},
year = {2024},
doi = {10.63032/idqb5912}
}
EUVIMED